Bone BiologicsBBLG
13F holders, Q4 2025 (December 31)7holders
2new positions
2sold out
1famous investor
$1.45avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Bone Biologics Corp. (BBLG) in their 13F filings, unchanged from Q3 2025. 2 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($34K), Two Sigma Investments, LP ($16K) and Citadel Advisors ($16K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070600
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $32K |
| Exits | 2 | $960 |
All 13F filers, Q3 2025 → Q4 2025: 38,273 shares bought and 344 shares sold, net +37,929 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| DRW Securities, LLC | 0.00% | Add +113.8% | 23,576 | $34K |
| Two Sigma Investments, LP | 0.00% | New | 11,083 | $16K |
| Citadel Advisors | 0.00% | New | 10,844 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +130.8% | 3,379 | $5K |
| UBS Group AG | 0.00% | Add +2851.5% | 1,948 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 230 | $334 |
| Bank of America Corp. | 0.00% | No change | 14 | $20 |
"% of holder's portfolio" is BBLG's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.